BR0011363A - Quimera il6ril6 para o tratamento de doenças neurodegenerativas - Google Patents

Quimera il6ril6 para o tratamento de doenças neurodegenerativas

Info

Publication number
BR0011363A
BR0011363A BR0011363-8A BR0011363A BR0011363A BR 0011363 A BR0011363 A BR 0011363A BR 0011363 A BR0011363 A BR 0011363A BR 0011363 A BR0011363 A BR 0011363A
Authority
BR
Brazil
Prior art keywords
treatment
neurodegenerative diseases
il6ril6 chimera
il6ril6
chimera
Prior art date
Application number
BR0011363-8A
Other languages
English (en)
Inventor
Michel Revel
Judith Chebath
Marina Pizzi
Pierfranco Spano
Ursula Boschert
Original Assignee
Yeda Res & Dev
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev, Applied Research Systems filed Critical Yeda Res & Dev
Publication of BR0011363A publication Critical patent/BR0011363A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção: "QUIMERA IL6RIL6 PARA O TRATAMENTO DE DOENçAS NEURODEGENERATIVAS". A invenção refere-se ao uso de quimera IL6RiL6 no tratamento e prevenção de distúrbios e doenças neurológicas.
BR0011363-8A 1999-06-21 2000-06-21 Quimera il6ril6 para o tratamento de doenças neurodegenerativas BR0011363A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL13058699A IL130586A0 (en) 1999-06-21 1999-06-21 IL6RIL6 chimera for the treatment of demyelinating diseases
PCT/IL2000/000363 WO2000078331A2 (en) 1999-06-21 2000-06-21 Il6ril6 chimera for the treatment of neurodegenerative diseases

Publications (1)

Publication Number Publication Date
BR0011363A true BR0011363A (pt) 2002-02-26

Family

ID=11072949

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0011363-8A BR0011363A (pt) 1999-06-21 2000-06-21 Quimera il6ril6 para o tratamento de doenças neurodegenerativas

Country Status (21)

Country Link
US (1) US7201896B1 (pt)
EP (1) EP1185293B1 (pt)
JP (1) JP4846148B2 (pt)
KR (1) KR100678290B1 (pt)
CN (1) CN1164328C (pt)
AT (1) ATE306280T1 (pt)
AU (1) AU778662B2 (pt)
BR (1) BR0011363A (pt)
CA (1) CA2374997C (pt)
DE (1) DE60023139T2 (pt)
DK (1) DK1185293T3 (pt)
EA (1) EA004626B1 (pt)
EE (1) EE05559B1 (pt)
ES (1) ES2250140T3 (pt)
HK (1) HK1047549A1 (pt)
IL (2) IL130586A0 (pt)
MX (1) MXPA02000116A (pt)
NO (1) NO329028B1 (pt)
UA (1) UA76695C2 (pt)
WO (1) WO2000078331A2 (pt)
ZA (1) ZA200109488B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1317273T3 (da) * 2000-09-14 2006-09-04 Ares Trading Sa Anvendelse af IL-6R/IL-6-kimærer mod Huntingtons sygdom
DE10107737A1 (de) * 2001-02-16 2002-09-05 S Rose John Christian Albrecht Verwendung eines Konjugats aus IL-6 und einem IL-6 Rezeptor zur Tumortherapie
WO2002084249A2 (en) * 2001-04-10 2002-10-24 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic and diagnostic uses of antibody specificity profiles
IL147412A0 (en) 2001-12-31 2002-08-14 Yeda Res & Dev The use of il6r/il6 chimera in nerve cell regeneration
WO2004111210A1 (en) * 2003-06-12 2004-12-23 Yeda Research & Development Co.Ltd Enhancement of oligodendrocyte differentiation
EP1692273A1 (en) * 2003-11-14 2006-08-23 Mats J. Olsson Melanocytes in therapy of neurodegenerative diseases
IL161672A0 (en) * 2004-04-29 2004-09-27 Yeda Res & Dev Compositions and methods for therapy of chemotherapy-induced neuropathy
IL163856A0 (en) * 2004-09-01 2005-12-18 Applied Research Systems Use of IL-6 in vascular complications
WO2017139736A1 (en) * 2016-02-12 2017-08-17 Als Therapy Development Institute Measurement of als progression based on kinetic data
WO2018056412A1 (ja) * 2016-09-23 2018-03-29 国立大学法人大阪大学 シュワン細胞分化促進剤及び末梢神経再生促進剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL122818A0 (en) * 1997-07-10 1998-08-16 Yeda Res & Dev Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof
JPH1148413A (ja) 1997-08-06 1999-02-23 Dainippon Printing Co Ltd ホルムアルデヒド捕捉壁紙およびその製造方法
JP4859153B2 (ja) * 1999-02-25 2012-01-25 東ソー株式会社 新規神経系細胞分化促進剤

Also Published As

Publication number Publication date
EE200100689A (et) 2003-02-17
CA2374997C (en) 2010-04-13
NO329028B1 (no) 2010-08-02
MXPA02000116A (es) 2003-07-21
US7201896B1 (en) 2007-04-10
EP1185293A2 (en) 2002-03-13
WO2000078331A3 (en) 2001-07-05
KR100678290B1 (ko) 2007-02-05
JP2003502382A (ja) 2003-01-21
IL130586A0 (en) 2000-06-01
KR20020013901A (ko) 2002-02-21
CN1364088A (zh) 2002-08-14
NO20015673L (no) 2001-12-17
DK1185293T3 (da) 2005-12-27
EE05559B1 (et) 2012-08-15
JP4846148B2 (ja) 2011-12-28
EA200200063A1 (ru) 2002-06-27
WO2000078331A2 (en) 2000-12-28
HK1047549A1 (en) 2003-02-28
ZA200109488B (en) 2002-11-18
ATE306280T1 (de) 2005-10-15
EP1185293B1 (en) 2005-10-12
ES2250140T3 (es) 2006-04-16
CA2374997A1 (en) 2000-12-28
NO20015673D0 (no) 2001-11-20
AU5423100A (en) 2001-01-09
DE60023139D1 (de) 2006-02-23
CN1164328C (zh) 2004-09-01
UA76695C2 (uk) 2006-09-15
EA004626B1 (ru) 2004-06-24
AU778662B2 (en) 2004-12-16
IL147188A (en) 2015-09-24
DE60023139T2 (de) 2006-05-04

Similar Documents

Publication Publication Date Title
DE60037013D1 (de) Neurotropische substituierte pyrimidine
NO20034056D0 (no) Proliferative sykdommer
TW200800976A (en) New compounds for the treatment of neurological, psychiatric or pain disorders
YU37602A (sh) Derivat pirolidinacetamida sam ili u kombinaciji za tretman poremećaja cns
CY2014005I1 (el) Τοπικα συστηματα παροχης γελης για την θεραπευτικη αντιμετωπιση των διαταραχων δερματος
PT1446122E (pt) Utilizacao de flibanserina no tratamento de disturbios de desejo sexual
BRPI0407662A (pt) derivados do ácido 1-fenilalcanocarboxìlico para o tratamento de doenças neurodegenerativas
EE200300559A (et) Osteopontiini kasutamine neuroloogiliste haigusteraviks ja/või vältimiseks
MY124786A (en) Bis-arylsulfones
IL171384A (en) Use of slurp-1 in the preparation of medicaments for the treatment of neurological disorders
NZ333232A (en) Use of p-aminophenol derivatives (paracetamol) to treat neurodegenerative disease
BR0011363A (pt) Quimera il6ril6 para o tratamento de doenças neurodegenerativas
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
BRPI0408889A (pt) uso de clusterina para o tratamento e/ou prevenção de doenças neurológicas periféricas
MX2007007206A (es) Uso de un agonista 5-ht6 para el tratamiento y la prevencion de trastornos neurodegenerativos.
WO2005046605A3 (en) Compositions and methods of treating neurological diseases
PT1135134E (pt) Utilizacao de estimuladores do factor neurotrofico para o tratamento de doencas oftalmicas neurodegenerativas
HUP0301553A3 (en) Pharmaceutical compositions and their use for treating neurological disorders
CA2534303A1 (en) Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
PL373490A1 (en) Use of beta-adrenoceptor agonists for the treatment of neurodegenerative diseases
ATE314064T1 (de) L-acetylcarnitin und l-propionylcarnitin zusammensetzung zur verhütung und behandlung von nierenstörungen und nierenenkrankheit
EE200200698A (et) Ravimid neurodegeneratiivsete haiguste ennetamiseks ja raviks
BR0314364A (pt) Uso de inibidores de pde iv para tratar angiogênese
PE37398A1 (es) Composiciones para la prevencion y tratamiento de transtornos gastrointestinales
SI1185293T1 (sl) Uporaba himer il6ril6 za zdravljenje nevrodegenerativnih bolezni

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) , LABO

Free format text: TRANSFERIDO DE: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O C/C 11 E 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B25D Requested change of name of applicant approved

Owner name: YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) , MERC